ClinPhenomics GmbH & Co KG, Frankfurt

Frankfurt 60596

0 studies enrolling now · 4 studies all time

What they study most

Chronic Kidney Disease, Diabetes Mellitus, Type 2, Heart Failure

Studies at this site

• EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed
• Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) — Completed